First Time Tirzepatide
US$ 29.05
![glp 1 agonists and depression GLP-1 Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1s associated with reduced risk](https://www.preprints.org/frontend/picture/ms_xml/manuscript/c9c3cd16d3db64faa79714c50b5bb790/preprints-181961-g001.png)
glp 1 agonists and depression GLP-1 Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1s associated with reduced risk
Description
Zhu C, Lai Y, Liu C, Teng L, Zhu Y, Lin X, et al
![glp 1 agonists and depression GLP-1 Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1s associated with reduced risk](https://www.healio.com/~/media/slack-news/fm_im/misc/infographics/2024/02-february/pc0224bartelt2_graphic_01_web.jpg)
Recent studies have sparked a debate on whether GLP-1 receptor agonists are beneficial or detrimental in the context of colorectal cancer
![glp 1 agonists and depression GLP-1 Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1s associated with reduced risk](https://www.mdpi.com/life/life-15-01422/article_deploy/html/images/life-15-01422-g001.png)
[DOI] [PubMed] [Google Scholar] 35.Shah M, Vella A
![glp 1 agonists and depression GLP-1 Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1s associated with reduced risk](https://www.frontiersin.org/files/Articles/721135/xml-images/fendo-12-721135-g001.webp)
Effects of semaglutide on symptoms, function, and quality of life in patients with heart failure with preserved ejection fraction and obesity: a prespecified analysis of the STEP-HFpEF trial
![glp 1 agonists and depression GLP-1 Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1s associated with reduced risk](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3864440566747282754)
American Kidney Fund
![glp 1 agonists and depression GLP-1 Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] GLP-1s associated with reduced risk](https://www.psychiatrist.com/wp-content/uploads/2026/05/Prevalence-GLP-1-Receptor-Agonist-Use-Privately-Insured-Individuals-Mood-Disorders-JCP-f1.png)
If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected] .